LyophilizedPowderThisproductisfreezedried.Allwatermoleculeshavebeenremoved.
AntigenIncl.ThisantibodyisshippedwithitsantigenFREEofcharge!
- PeptideNKSLSSFKENEENIQC,correspondingtoaminoacidresidues84-99ofratCB1receptor(Accession P20272).Extracellular,N-terminus.

Westernblotanalysisofratbrainmembraneproteins:1. Anti-CannabinoidReceptor1(extracellular) Antibody(#ACR-001),(1:200).
2.Anti-CannabinoidReceptor1(extracellular)Antibody,preincubatedwiththecontrolpeptideantigen.
ExpressionofCB1receptorinmousehippocampusImmunohistochemicalstainingof mousehippocampususing Anti-CannabinoidReceptor1(extracellular) Antibody(#ACR-001),(1:100).A.CB1isdetectedinpyramidalandinfra-pyramidallayers(green).B.Stainingofinterneuronsusingmouseanti-parvalbumin(PV)antibody(red).C.ConfocalmergeofAandBdoesnotindicatethepresenceofCB1inGABAergiccells.
ExpressionofCB1receptorinrat hippocampusImmunohistochemicalstainingofrathippocampususing Anti-CannabinoidReceptor1(extracellular) Antibody(#ACR-001)(1:100).A.CB1isdetected inpyramidalandinfra-pyramidallayers(green).B.Stainingofinterneuronsusingmouseanti-parvalbumin(PV)antibody(red).C.Confocalmergeof AandB doesnot indicatethe presenceofCB1inGABAergiccells.
- Ratculturedhippocampalneurons(1:100forlivecells,1:500-1:100forfixedandpermeabilizedcells)(McDonald,N.A. etal. (2007) Mol.Pharmacol. 71, 976.).
- 1.Brooks,J.W.andFraquhar-Smith,M.A.(2003)Br.J.Anaesth.3,175.
- 2.Howlett,A.C.(2002)ProstaglandinsOtherLipidMediat.68–69,619.
- 3.Howlett,A.C.etal.(2002)Pharmacol.Rev.54,161.
- 4.Rueda,D.etal.(2000)Mol.Pharmacol.58,814.
- 5.Sarfaraz,S.etal.(2005)CancerRes.65,1635.
- 6.Casanova,M.L.etal.(2003)J.Clin.Invest.111,43.
- 7.Cota,D.etal.(2003)Int.J.Obes.Relat.Metab.Disord.27,289.
CannabinoidshavebeenusedinEasternmedicineformanyyearsaspainrelievers.1 Δ9-tetrahydrocannabinol(THC),themajorpsychoactivecompoundinmarijuanaandhashish,hasbeenshowntointeractwithtwospecificcannabinoidreceptors:cannabinoidreceptor1(CB1receptor)andcannabinoidreceptor2(CB2receptor).2 Thecannabinoidreceptorscanbedistinguishedbytheiraminoacidsequences,signalingmechanisms,andtissuedistributions.2 BothreceptorsbelongtotheG-proteincoupledreceptor(GPCR)superfamily.CB1wasshowntomodulateseveralCa2+ andK+ ionchannels.2,3
CB1isprimarilyexpressedinthecentralnervoussystem.However,expressionofCB1isalsodetectedintheperipheralterminals,innon-neuronalperipheraltissuessuchasuterus,testes,spleen,aswellasincellsoftheimmunesystem.3,4
CB1isimplicatedinmanycellularfunctionssuchasneurotransmitterrelease,painrelief,cancer,andobesity.5,6 GrowthinhibitionoftumorcellswasdemonstratedfollowingmixedCB1/CB2agoNISTtreatmentinbothprostateandnon-melanomaskincancers.5,6 ThroughtheirinteractionwithCB1,cannabinoidcompoundsstimulateappetiteforsweetsandpalatablefoodsinparticular,makingCB1anattractivetherapeutictargetforthetreatmentofobesityandeatingdisorders.7

Immuno-colocalizationofproNGFandCannabinoidReceptor1inmousehippocampaldentategyrusImmunohistochemicalstainingofimmersion-fixed,freefloatingmousebrainfrozensectionsusingGuineapigAnti-proNGFAntibody (#AGP-031),(1:300)andrabbit Anti-CannabinoidReceptor1(extracellular) Antibody(#ACR-001),(1:300).A.proNGFstaining(red)appearsinthedentategyrus(DG)granulelayer(G)andinhilarinterneurons(arrows).B.CB1staining(green)appearsinaxonalprocessessurroundingthegranulelayerandafewhilarinterneurons(arrows).C.Mergeofthetwoimagesrevealsco-localizationofproNGFandCB1inafewhilarcells.CellnucleiwerestainedwithDAPI(blue).
Anti-CannabinoidReceptor1(extracellular)Antibody(#ACR-001)isahighlyspecificantibodydirectedagainstanepitopeoftheratCB1receptor.Theantibodycanbeusedinwesternblot,immunohistochemistry,andlivecellimagingapplications.IthasbeendesignedtorecognizeCB1inhuman,mouse,andratsamples.


